Literature DB >> 19851045

Cisplatin ototoxicity and protection: clinical and experimental studies.

Leonard P Rybak1, Debashree Mukherjea, Sarvesh Jajoo, Vickram Ramkumar.   

Abstract

Cisplatin is a chemotherapeutic agent that is widely used to treat a variety of malignant tumors. Serious dose-limiting side effects like ototoxicity, nephrotoxicity and neurotoxicity occur with the use of this agent. This review summarizes recent important clinical and experimental investigations of cisplatin ototoxicity. It also discusses the utility of protective agents employed in patients and in experimental animals. The future strategies for limiting cisplatin ototoxicity will need to avoid interference with the therapeutic effect of cisplatin in order to enhance the quality of life of patients receiving this important anti-tumor agent.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19851045      PMCID： PMC2927105          DOI： 10.1620/tjem.219.177

Source DB:  PubMed          Journal:  Tohoku J Exp Med        ISSN： 0040-8727            Impact factor:   1.848


  98 in total

1.  Protection against cisplatin ototoxicity by adenosine agonists.

Authors:  Craig A Whitworth; Vickram Ramkumar; Brett Jones; Naoki Tsukasaki; Leonard P Rybak
Journal:  Biochem Pharmacol       Date:  2004-05-01       Impact factor: 5.858

2.  Protein kinase Cdelta regulates apoptosis via activation of STAT1.

Authors:  Tracie A DeVries; Rachelle L Kalkofen; Angela A Matassa; Mary E Reyland
Journal:  J Biol Chem       Date:  2004-08-20       Impact factor: 5.157

3.  Mechanisms of apoptosis induced by cisplatin in marginal cells in mouse stria vascularis.

Authors:  Ji Eun Lee; Takayuki Nakagawa; Tomoko Kita; Tae Soo Kim; Fukuichiro Iguchi; Tsuyoshi Endo; Atsushi Shiga; Sang Heun Lee; Juichi Ito
Journal:  ORL J Otorhinolaryngol Relat Spec       Date:  2004       Impact factor: 1.538

4.  Epigallocatechin-3-gallate inhibits STAT-1 activation and protects cardiac myocytes from ischemia/reperfusion-induced apoptosis.

Authors:  Paul A Townsend; Tiziano M Scarabelli; Evasio Pasini; Gianluca Gitti; Marta Menegazzi; Hisanori Suzuki; Richard A Knight; David S Latchman; Anastasis Stephanou
Journal:  FASEB J       Date:  2004-08-19       Impact factor: 5.191

Review 5.  The eukaryotic nucleotide excision repair pathway.

Authors:  Renata M A Costa; Vanessa Chiganças; Rodrigo da Silva Galhardo; Helotonio Carvalho; Carlos F M Menck
Journal:  Biochimie       Date:  2003-11       Impact factor: 4.079

6.  Platinum compound-related ototoxicity in children: long-term follow-up reveals continuous worsening of hearing loss.

Authors:  Patrizia Bertolini; Mathilde Lassalle; Guilaine Mercier; Marie Anne Raquin; Giancarlo Izzi; Nadege Corradini; Olivier Hartmann
Journal:  J Pediatr Hematol Oncol       Date:  2004-10       Impact factor: 1.289

7.  Increased expression of the copper efflux transporter ATP7A mediates resistance to cisplatin, carboplatin, and oxaliplatin in ovarian cancer cells.

Authors:  Goli Samimi; Roohangiz Safaei; Kuniyuki Katano; Alison K Holzer; Myriam Rochdi; Mika Tomioka; Murray Goodman; Stephen B Howell
Journal:  Clin Cancer Res       Date:  2004-07-15       Impact factor: 12.531

Review 8.  Transtympanic perfusion: indications and limitations.

Authors:  Joshua P Light; Herbert Silverstein
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2004-10       Impact factor: 2.064

9.  WR-2721 (Amifostine) ameliorates cisplatin-induced hearing loss but causes neurotoxicity in hamsters: dose-dependent effects.

Authors:  Michael W Church; Brian W Blakley; Don L Burgio; Anil K Gupta
Journal:  J Assoc Res Otolaryngol       Date:  2004-05-20

10.  Protection against cisplatin-induced ototoxicity by N-acetylcysteine in a rat model.

Authors:  D Thomas Dickey; Leslie L Muldoon; Dale F Kraemer; Edward A Neuwelt
Journal:  Hear Res       Date:  2004-07       Impact factor: 3.208
View more
  101 in total

1.  Curcumin enhances cisplatin sensitivity by suppressing NADPH oxidase 5 expression in human epithelial cancer.

Authors:  Siqi Chen; Wei Gao; Min-Juan Zhang; Jimmy Yu-Wai Chan; Thian-Sze Wong
Journal:  Oncol Lett       Date:  2019-06-14       Impact factor: 2.967

2.  Protective role of misoprostol against cisplatin-induced ototoxicity.

Authors:  Murat Doğan; Halil Polat; Mehmet Yaşar; Altan Kaya; Ali Bayram; Fatma Şenel; İbrahim Özcan
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-04-06       Impact factor: 2.503

3.  Cisplatin ototoxicity affecting cochlear implant benefit.

Authors:  Michael S Harris; Jaimie L Gilbert; Kelly A Lormore; Swapna A Musunuru; Michael H Fritsch
Journal:  Otol Neurotol       Date:  2011-08       Impact factor: 2.311

4.  Cisplatin-induced ototoxicity and the role of pharmacogenetic testing.

Authors:  Lauren E Wyatt; Mary Jayne Kennedy
Journal:  J Pediatr Pharmacol Ther       Date:  2012-10

Review 5.  Platinum-induced ototoxicity: a review of prevailing ototoxicity criteria.

Authors:  Sofia Waissbluth; Emilia Peleva; Sam J Daniel
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-05-31       Impact factor: 2.503

6.  Effects of ozone (O3) therapy on cisplatin-induced ototoxicity in rats.

Authors:  Hasan Emre Koçak; Ümit Taşkın; Salih Aydın; Mehmet Faruk Oktay; Serdar Altınay; Duygu Sultan Çelik; Kadir Yücebaş; Bengül Altaş
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-05-24       Impact factor: 2.503

7.  Systemic application of honokiol prevents cisplatin ototoxicity without compromising its antitumor effect.

Authors:  Xiaodong Tan; Yingjie Zhou; Aditi Agarwal; Michelle Lim; Yingyue Xu; Yueming Zhu; Joseph O'Brien; Elizabeth Tran; Jing Zheng; David Gius; Claus-Peter Richter
Journal:  Am J Cancer Res       Date:  2020-12-01       Impact factor: 6.166

8.  Protective effect of acetyl-l-carnitine against cisplatin ototoxicity: role of apoptosis-related genes and pro-inflammatory cytokines.

Authors:  Z Altun; Y Olgun; P Ercetin; S Aktas; G Kirkim; B Serbetcioglu; N Olgun; E A Guneri
Journal:  Cell Prolif       Date:  2013-11-29       Impact factor: 6.831

Review 9.  Mechanisms of Cisplatin-Induced Acute Kidney Injury: Pathological Mechanisms, Pharmacological Interventions, and Genetic Mitigations.

Authors:  Kristen Renee McSweeney; Laura Kate Gadanec; Tawar Qaradakhi; Benazir Ashiana Ali; Anthony Zulli; Vasso Apostolopoulos
Journal:  Cancers (Basel)       Date:  2021-03-29       Impact factor: 6.639

10.  The effect of intratympanic vitamin C administration on cisplatin-induced ototoxicity.

Authors:  Saban Celebi; M Mustafa Gurdal; M Haluk Ozkul; Husamettin Yasar; H Huseyin Balikci
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-08-21       Impact factor: 2.503
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.